Get answers about your liver
The HelioLiver test helps you learn about your risk for liver cancer and be proactive about your care. HelioLiver is now available for clinical use as a laboratory-developed test (LDT).
Less than half of all liver cancer are diagnosed before it spreads.
The current testing methods can’t always detect liver cancer in the earliest stages. Once you’ve been diagnosed as at-risk for liver cancer, you know it’s important to keep up with routine liver cancer testing.
Introducing The HelioLiver LDT
The HelioLiver laboratory-developed test is a testing method that has been shown in clinical trials to detect liver in early stages. With a simple blood draw, this test provides early detection insights that help you be proactive about your health.
Simple, highly sensitive, and readily available
Just get one blood draw during your routine doctor’s visit that takes no more than 5 minutes
Our test is more sensitive than other currently available surveillance methods with simple, easy-to-understand results
We can bill most insurances, and accept all commercial and federal plans.
Ready to get started? Talk to your doctor today
If you are at-risk for liver cancer and over the age of 21, then you are eligible for HelioLiver LDT.
Download our discussion guide to take to your next appointment to discuss with your doctor if the HelioLiver LDT is right for you
Get in touch
Fill out this short form and someone from the HelioLiver LDT team will be in touch!